<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT03473275</url>
  </required_header>
  <id_info>
    <org_study_id>2018-00105</org_study_id>
    <nct_id>NCT03473275</nct_id>
  </id_info>
  <brief_title>Brain BOLD fMRI in Hypertensive and Normotensive Participants</brief_title>
  <acronym>BRAIrdN</acronym>
  <official_title>Central Blood Pressure Regulation by the Brainstem and Influence by Renal Sympathetic Afference: a Functional Magnetic Resonance Imaging (MRI) Study in Hypertensive and Normotensive Participants</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>Centre Hospitalier Universitaire Vaudois</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
    <collaborator>
      <agency>Ecole Polytechnique Fédérale de Lausanne</agency>
      <agency_class>Other</agency_class>
    </collaborator>
  </sponsors>
  <source>Centre Hospitalier Universitaire Vaudois</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
    <is_fda_regulated_drug>No</is_fda_regulated_drug>
    <is_fda_regulated_device>No</is_fda_regulated_device>
  </oversight_info>
  <brief_summary>
    <textblock>
      This study will explore the brainstem activity in response to stress in hypertensive patients
      and normotensive subjects. In addition, it will evaluate if the response in hypertensive
      patients can be modulated by blocking the afferent signalling of sympathetic nervous system
      from the kidney to the brain achieved by renal denervation.

      The investigators hypothesize that the change in BOLD signal intensity in response to stress
      is higher in hypertensive patients than in normotensive subjects and that in patients
      responsive to renal denervation the change in BOLD signal intensity in response to stress is
      decreased compared to non-responders or to non-denervated resistant hypertensive patients.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      In hypertension, the overactivity of the sympathetic nervous system (SNS) has been found to
      be implicated in its initiation, maintenance and adverse consequences. The SNS is composed of
      an afferent and efferent arm, which brings sensory information to the brain (e.g. brainstem
      and hypothalamus) and transmits sympathetic outflow from the brain to the peripheral organs,
      respectively. Selective removal of the afferent renal component of the SNS can modulate
      central sympathetic outflow to the kidney, heart and vasculature in animals. The specific
      contribution of afferent nerve signalling in hypertension and in the potential
      antihypertensive effect of renal denervation has not been studied in humans.
    </textblock>
  </detailed_description>
  <overall_status>Not yet recruiting</overall_status>
  <start_date type="Anticipated">April 2018</start_date>
  <completion_date type="Anticipated">March 2022</completion_date>
  <primary_completion_date type="Anticipated">March 2021</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Case-Control</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Change in BOLD signal intensity</measure>
    <time_frame>2 hours</time_frame>
    <description>Changes in the BOLD fMRI signal of the brainstem in response to a cold pressor test</description>
  </primary_outcome>
  <number_of_groups>4</number_of_groups>
  <enrollment type="Anticipated">92</enrollment>
  <condition>Hypertension,Essential</condition>
  <arm_group>
    <arm_group_label>1: control</arm_group_label>
    <description>Healthy normotensive participants. Cold pressor test on feet 6 times for 1 minute during BOLD fMRI</description>
  </arm_group>
  <arm_group>
    <arm_group_label>2: untreated hypertensive</arm_group_label>
    <description>Untreated (or off antihypertensive drugs) hypertensive patients (ABPM proven essential hypertension).
Cold pressor test on feet 6 times for 1 minute during BOLD fMRI</description>
  </arm_group>
  <arm_group>
    <arm_group_label>3. resistant hypertensive</arm_group_label>
    <description>Patients with proven resistant hypertension and not renal denervated. Cold pressor test on feet 6 times for 1 minute during BOLD fMRI</description>
  </arm_group>
  <arm_group>
    <arm_group_label>4. renal denervation</arm_group_label>
    <description>Patients with a renal denervation or for whom a renal denervation is planned according to the criteria of the CHUV.
Cold pressor test on feet 6 times for 1 minute during BOLD fMRI</description>
  </arm_group>
  <intervention>
    <intervention_type>Diagnostic Test</intervention_type>
    <intervention_name>Cold Pressor test</intervention_name>
    <description>Ice-cold gel-packs around both feet during BOLD fMRI</description>
    <arm_group_label>1: control</arm_group_label>
    <arm_group_label>2: untreated hypertensive</arm_group_label>
    <arm_group_label>3. resistant hypertensive</arm_group_label>
    <arm_group_label>4. renal denervation</arm_group_label>
  </intervention>
  <biospec_retention>Samples Without DNA</biospec_retention>
  <biospec_descr>
    <textblock>
      plasma: cathecholamines, plasma renin activity (PRA), Aldosterone, Neuropeptide Y (NPY)
    </textblock>
  </biospec_descr>
  <eligibility>
    <study_pop>
      <textblock>
        Healthy normotensive participants: university employees mainly Hypertensive patients: from
        the outpatient clinic of the Nephrology Service Resistant hypertensive patients (renal
        denervated and non-denervated): from the outpatient clinic of the Nephrology Service
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  signed informed consent

          -  capable of discernment

        Exclusion Criteria:

          -  having contra-indications for MRI (claustrophobia, cardiac pacemaker or other metallic
             or mechanical implant or device, etc.)

          -  pregnant women

          -  lower limb sensitive neuropathy

          -  Blood pressure &gt;180/110 mmHg during washout period (for hypertensive patients)

          -  Intolerance to Sonovue®(ultrasound contrast agent)

          -  no medication/drugs, except of calcium channel blockers for resistant hypertensive
             patients
      </textblock>
    </criteria>
    <gender>All</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>Accepts Healthy Volunteers</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Gregoire Wuerzner, MD</last_name>
    <role>Principal Investigator</role>
    <affiliation>Centre Hospitalier Universitaire Vaudois</affiliation>
  </overall_official>
  <overall_contact>
    <last_name>Gregoire Wuerzner, MD</last_name>
    <phone>+41 21 314 02 23</phone>
    <email>gregoire.wuerzner@chuv.ch</email>
  </overall_contact>
  <verification_date>March 2018</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>March 15, 2018</study_first_submitted>
  <study_first_submitted_qc>March 15, 2018</study_first_submitted_qc>
  <study_first_posted type="Actual">March 22, 2018</study_first_posted>
  <last_update_submitted>March 22, 2018</last_update_submitted>
  <last_update_submitted_qc>March 22, 2018</last_update_submitted_qc>
  <last_update_posted type="Actual">March 23, 2018</last_update_posted>
  <responsible_party>
    <responsible_party_type>Principal Investigator</responsible_party_type>
    <investigator_affiliation>Centre Hospitalier Universitaire Vaudois</investigator_affiliation>
    <investigator_full_name>PD Dr. Grégoire Wuerzner</investigator_full_name>
    <investigator_title>Primary Investigator, MD</investigator_title>
  </responsible_party>
  <keyword>Sympathetic nervous system</keyword>
  <keyword>Blood oxygen level dependent</keyword>
  <keyword>Brainstem</keyword>
  <keyword>Contrast enhanced ultrasound</keyword>
  <keyword>Kidney function</keyword>
  <keyword>Hypertension</keyword>
  <keyword>Renal denervation</keyword>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Hypertension</mesh_term>
  </condition_browse>
  <patient_data>
    <sharing_ipd>Yes</sharing_ipd>
    <ipd_description>Anonymized data of participants that have signed the consent allowing their anonymized data to be shared, will be made available via the repository Zenodo</ipd_description>
  </patient_data>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

